{"schema_version":"secwatch.filing_event.v1","accession":"0001549595-24-000073","form_type":"8-K","ticker":"NRIX","cik":"0001549595","company_name":"Nurix Therapeutics, Inc.","filed_at":"2024-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.920665+00:00","generated_at":"2026-06-01T10:52:05.381525+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Nurix Therapeutics annual meeting: stockholders elect directors, ratify auditor, approve say-on-pay","bullets":["Stockholders elected directors Julia P. Gregory (29.9M for, 4.5M withheld) and David L. Lacey (27.1M for, 7.3M withheld) to terms expiring 2027.","Ratified PricewaterhouseCoopers LLP as independent auditor for FY ending Nov 30, 2024 (39.0M for, 16.7K against).","Non-binding advisory vote on named executive officer compensation passed: 30.4M for, 4.0M against, 77.4K abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001549595-24-000073","json":"https://secwatch.observer/filing/0001549595-24-000073.json","markdown":"https://secwatch.observer/filing/0001549595-24-000073.md","text":"https://secwatch.observer/filing/0001549595-24-000073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549595/000154959524000073/0001549595-24-000073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549595/000154959524000073/nrix-20240520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T10:52:05.381525+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}